格隆汇10月2日丨再鼎医药(09688.HK)公告,于2025年10月1日(美国东部时间),公司根据2024年股权激励计划向1名承授人授出可认购合共2.5万股美国存托股份的购股权并向7名承授人涉及合共32,150股美国存托股份的受限制股份单位。

本文地址: http://www.jiaotongmi.com/article/13203.html
文章来源:admin
版权声明:除非特别标注,否则均为本站原创文章,转载时请以链接形式注明文章出处。
2025-11-09admin
2025-11-08admin
2025-11-07admin
2025-11-06admin
2025-11-05admin
2025-11-04admin
2025-11-03admin
2025-10-29admin
2025-10-29admin
2025-10-29admin
2025-09-08admin
2025-09-13admin
2025-09-08admin
2025-09-17admin
2025-09-17admin
2025-09-08admin
2025-09-09admin
2025-09-09admin
2025-09-13admin
2025-09-11admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
2025-09-08admin
扫码二维码
获取最新动态
